Page breadcrumb nav

VAERS Report 2157102

Case Report Section

Vaer Report Details

Age: NA

Gender: Female

State: Outside US

Patient Died?
No
Vaccine information

Name: COVID19 (COVID19 (PFIZER-BIONTECH))

Type: Coronavirus 2019 vaccine

Manufacturer: PFIZER

Lot: unknown


Date report was received
2022-03-04
Date form completed
Date Vaccinated
2021-12-01
Date of Onset
31
Number of days (onset date – vaccination date)
31
Adverse Event Description

breast carcinoma; this is a spontaneous report received from contactable healthcare professional (hcp). a 45 year-old female patient (not pregnant) received bnt162b2 (comirnaty), intramuscular, administration date dec2021 (lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. there was no relevant medical history. concomitant medications were not reported. vaccination history included: comirnaty (dose number: 2, batch/lot no: unknown. not available/provided to reporter at the time of report completion), administration date: jun2021, for covid-19 immunisation; comirnaty (dose number: 1, batch/lot no: unknown. not available/provided to reporter at the time of report completion), administration date: may2021, for covid-19 immunisation. the patient did not receive any other vaccines within 4 weeks prior to the covid vaccine. prior to vaccination, the patient was not diagnosed with covid-19. the following information was reported: breast carcinoma (hospitalization in jan2022, life threatening) with onset jan2022. the patient underwent regular gynecological testing a month after the third dose of the comirnaty vaccine in jan2022. digital mammography, ultrasound and palpation showed an oversized tumor in the right breast and an urgent biopsy was decided which confirmed malignancy in jan2022. the event breast carcinoma was evaluated at the physician office visit. a mastectomy was performed, the other imaging and hematological examinations showed no signs of other malignancy or metastasis in jan2022. after the surgical recovery, the patient has already started chemotherapy. the outcome of the event breast carcinoma was recovering. since the vaccination, it was unknown if the patient been tested for covid-19. no follow-up attempts are possible; information about lot/batch number cannot be obtained. no further information is expected.; sender's comments: the event breast carcinoma is considered as intercurrent condition and unrelated to product bnt162b2 (comirnaty)

Lab Data
test date: 202201; test name: biopsy; result unstructured data: test result:confirmed malignancy; test date: 202201; test name: hematological examinations; result unstructured data: test result:showed no signs of other malignancy or metastasis; test date: 202201; test name: other imaging; result unstructured data: test result:showed no signs of other malignancy or metastasis; test date: 202201; test name: digital mammography; result unstructured data: test result:oversized tumor in the right breast; test date: 202201; test name: ultrasound; result unstructured data: test result:oversized tumor in the right breast
List of symptoms
biopsy breast cancer ultrasound scan haematology test normal mammogram imaging procedure
Patient Died?
No
Date Died
NA
Birth defect
false
Vaccine Administered By:
Other
Vaccine Purchased By:
Unknown
Patient visit ER?
No
Patient Hospitalized?
Yes
Stay in hospital
No
Days in hospital
Unspecified
Permanent disability?
No
Allergies:
na
Current Illness
na